Beranda › Kanker Prostat › Texas › League City
Uji klinis Kanker Prostat di League City, TX
4 studi untuk Kanker Prostat mencari peserta di lokasi sekitar League City (dalam radius sekitar 30 mil). Buka studi untuk melihat kriteria peserta dan cara menghubungi tim studi.
Teks studi resmi (Bahasa Inggris)
Merekrut peserta untuk studi di sini? Tampilkan di bagian atas halaman ini — $99 selama 30 hari →
Testing Shorter Duration Radiation Therapy Versus the Usual Radiation Therapy in Patients With High Risk Prostate Cancer
Menerima pesertaFase 3
- UT MD Anderson - League City, League City
Docetaxel to Androgen Receptor Pathway Inhibitors in Patients With Metastatic Castration Sensitive Prostate Cancer and Suboptimal PSA Response
Menerima pesertaFase 3
- Houston Methodist Saint John Hospital, Nassau Bay · 3 mi jauhnya
Testing Whether the Addition of Carboplatin Chemotherapy to Cabazitaxel Chemotherapy Will Improve Outcomes Compared to Cabazitaxel Alone in People With Castrate-Resistant Prostate Cancer That Has Spread Beyond the Prostate to Other Parts of the Body
Menerima pesertaFase 3
- MD Anderson League City, League City
Standard Systemic Therapy With or Without Definitive Treatment in Treating Participants With Metastatic Prostate Cancer
Menerima pesertaFase 3
- MD Anderson League City, League City
Uji klinis Kanker Prostat di kota lain
- New York City, NY103 studi
- Houston, TX76 studi
- Los Angeles, CA61 studi
- Boston, MA59 studi
- St. Louis, MO46 studi
- Chicago, IL45 studi
- San Francisco, CA45 studi
- Philadelphia, PA44 studi
- Baltimore, MD43 studi
- Nashville, TN43 studi
- Seattle, WA42 studi
- Washington, DC38 studi
Studi lain di League City
- Kanker Paru Non-Sel Kecil15 studi
- Kanker Payudara12 studi
- Kanker Metastatik7 studi
- Kolitis Ulseratif6 studi
- Kanker Paru6 studi
- Kanker Kolorektal6 studi
- Kanker (semua jenis)5 studi
- Kanker Ovarium5 studi
- Stroke5 studi
- Kanker Kandung Kemih4 studi
- Karsinoma Sel Skuamosa Kepala dan Leher4 studi
- Kondisi Pasca-COVID (Long COVID)3 studi
Dari ClinicalTrials.gov, data diambil 6 Okt 2026. Setiap studi menetapkan kriteria kelayakannya sendiri; tim studi yang menentukan siapa yang bisa bergabung.